Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
NA D'Angelo, MA Noronha, MCC Câmara… - Biomaterials …, 2022 - Elsevier
Doxorubicin (DOX) is a natural antibiotic with antineoplastic activity. It has been used for
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …
Synthesis of malformin‐A1, C, a glycan, and an aglycon analog: Potential scaffolds for targeted cancer therapy
Improvement in therapeutic efficacy while reducing chemotherapeutic side effects remains a
vital objective in synthetic design for cancer treatment. In keeping with the ethos of …
vital objective in synthetic design for cancer treatment. In keeping with the ethos of …
[PDF][PDF] Recent Advancements of Anti-cancer Nanomedicine in Breast Cancer
J Li - 2022 - scitepress.org
Nanomedicine is a novel type of cancer treatment that has been applied to clinical practice
for its identified safety and potency against cancer cells and safety. Conventional cancer …
for its identified safety and potency against cancer cells and safety. Conventional cancer …
Target-specific delivery of therapeutic agents
AL Klibanov, BA French, KA Kelly… - US Patent 11,369,569, 2022 - Google Patents
2018-04-18 Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), US DEPT. OF HEALTH
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …